| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Corp. Affairs Officer
1 company
Jones Aranthan II is a Chief Corp. Affairs Officer at Vanda Pharmaceuticals Inc.. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $489K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2021 | VNDA Vanda Pharmaceuticals Inc. | Chief Corp. Affairs Officer | Sale+OE | 16,824 | $16.49 | $277,394.11 | -17.0% | -2.4% | -37.9% | |
| Jul 26, 2021 | VNDA Vanda Pharmaceuticals Inc. | Chief Corp. Affairs Officer | Sell | 7,250 | $19.69 | $142,776.43 | -7.7% | -7.5% | -43.6% | |
| Mar 15, 2021 | VNDA Vanda Pharmaceuticals Inc. | Chief Corp. Affairs Officer | Sale+OE | 18,000 | $17.72 | $319,010.40 | -16.1% | +8.7% | -36.7% | |
| Mar 2, 2021 | VNDA Vanda Pharmaceuticals Inc. | Chief Corp. Affairs Officer | Sell | 3,865 | $18.04 | $69,717.26 | -3.8% | - | - | |
| Feb 24, 2021 | VNDA Vanda Pharmaceuticals Inc. | Chief Corp. Affairs Officer | Sale+OE | 22,986 | $20.01 | $460,032.61 | -18.6% | - | - | |
| Aug 12, 2020 | VNDA Vanda Pharmaceuticals Inc. | Chief Corp. Affairs Officer | Sell | 7,200 | $11.81 | $85,018.32 | -8.7% | - | - | |
| Jul 27, 2020 | VNDA Vanda Pharmaceuticals Inc. | Chief Corp. Affairs Officer | Sell | 7,313 | $10.62 | $77,631.15 | -8.1% | - | - |